You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lazertinib

Showing 1 - 25 of 27
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer Trial in Seoul (Lazertinib+Pemetrexed+Carboplatin, Lazertinib)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Aug 31, 2023

NSCLC Metastatic Trial in Seoul (Lazertinib, Tepotinib)

Not yet recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • Seoul, Gangnam-gu, Korea, Republic of
    Samsung Medical Center
Oct 27, 2023

Healthy Trial in Edegem (Lazertinib)

Not yet recruiting
  • Healthy
  • Lazertinib
  • Edegem, Belgium
    SGS Belgium NV
Jun 1, 2023

Lazertinib as the 2nd-Line Treatment in EGFR Mutation+ NSCLC

Completed
  • Non-small Cell Lung Cancer
  • Lazertinib
  • Platinum-based Chemotherapy
  • (no location specified)
May 8, 2023

Healthy Trial in Tempe (Lazertinib)

Recruiting
  • Healthy
  • Lazertinib
  • Tempe, Arizona
    Celerion
Feb 23, 2023

Lung Cancer Stage IV, EGFR T790M Trial in Seoul (Lazertinib)

Not yet recruiting
  • Lung Cancer Stage IV
  • EGFR T790M
  • Lazertinib
  • Seoul, MA, Korea, Republic of
    Samsung Medical Center
Jan 26, 2023

NSCLC Trial (Amivantamab, Lazertinib, Doxycycline)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Nov 7, 2023

Lazertinib Trial in Suwon-si, Goyang-si, Seoul (Lazertinib, Bevacizumab Injectable Product)

Recruiting
  • Lazertinib
  • Lazertinib
  • Bevacizumab Injectable Product
  • Suwon-si, Gyeonggi-do,, Korea, Republic of
  • +4 more
Nov 27, 2023

Hepatic Impairment, Healthy Trial in Kiel, Munchen (Lazertinib)

Completed
  • Hepatic Impairment
  • Healthy
  • Lazertinib
  • Kiel, Germany
  • +1 more
Nov 9, 2022

Healthy Trial in Salt Lake City (Lazertinib, Midazolam, Rosuvastatin)

Completed
  • Healthy
  • Lazertinib
  • +3 more
  • Salt Lake City, Utah
    PRA Health Sciences
Jun 22, 2022

Lazertinib Dose Modification on Effectiveness and Safety

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Lazertinib
  • Busan, Korea, Republic of
  • +10 more
Jan 29, 2023

NSCLC Trial in Seoul (Lazertinib)

Not yet recruiting
  • NSCLC
  • Lazertinib
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Mar 11, 2022

NSCLC Trial in Gyeonggi-do, Incheon, Seoul (Lazertinib, Pemetrexed, Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Lazertinib
  • +2 more
  • Gyeonggi-do, Korea, Republic of
  • +5 more
Jul 25, 2022

Metastatic Lung Non-Small Cell Carcinoma, EGFR T790M Trial in Seoul (Lazertinib)

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • EGFR T790M
  • Lazertinib
  • Seoul, Korea, Republic of
    Samsung Medical Center
May 18, 2022

Metastatic Non Small Cell Lung Cancer, Recurrent Non Small Cell Lung Cancer Trial in United States (Amivantamab, Lazertinib)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Recurrent Non Small Cell Lung Cancer
  • Basking Ridge, New Jersey
  • +6 more
Aug 1, 2022

NSCLC Stage III, EGFR Positive NSCLC, Non-squamous Non-small-cell Lung Cancer Trial in Korea, Republic of (Lazertinib)

Recruiting
  • Non-small Cell Lung Cancer Stage III
  • +2 more
  • Lazertinib
  • Busan, Korea, Republic of
  • +12 more
Jan 17, 2023

NSCLC Trial in Spain, United Kingdom, United States (Lazertinib)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Lazertinib
  • Duarte, California
  • +8 more
Jan 31, 2023

Non Small Cell Lung Cancer Trial in Worldwide (Amivantamab, Lazertinib, Zirabev)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Angers, France
  • +30 more
Oct 31, 2022

Healthy Trial in Tempe (Lazertinib, Itraconazole, Rifampin)

Completed
  • Healthy
  • Lazertinib
  • +2 more
  • Tempe, Arizona
    Celerion
Feb 25, 2021

NSCLC Trial in Worldwide (Dexamethasone, Montelukast, Methotrexate)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Fountain Valley, California
  • +17 more
Jan 31, 2023

NSCLC Trial in Worldwide (Lazertinib, Amivantamab, Carboplatin)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Lazertinib
  • +3 more
  • Los Angeles, California
  • +83 more
Jan 31, 2023

Advanced Solid Malignancies Trial in Worldwide (Ami-LC-MD, Ami-LC, Ami-HC)

Recruiting
  • Advanced Solid Malignancies
  • West Hollywood, California
  • +13 more
Jan 31, 2023

Non-Small-Cell Lung Cancer Trial in Worldwide (Amivantamab, Lazertinib, Carboplatin)

Recruiting
  • Non-Small-Cell Lung Cancer
  • Duarte, California
  • +100 more
Jan 31, 2023

NSCLC Trial in Worldwide (Amivantamab, Osimertinib, Lazertinib)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Goodyear, Arizona
  • +266 more
Aug 17, 2022

NSCLC Trial in Worldwide (Lazertinib, Amivantamab, Pemetrexed)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Lazertinib
  • +3 more
  • Phoenix, Arizona
  • +303 more
Aug 17, 2022